Skip to main content

Featured

OAS Payments Are Bigger This July — Here's How Much More You'll Get

  July 21, 2026 If you or someone in your family collects Old Age Security, the deposit landing later this month is larger than the last one. Here's exactly why, and what the new numbers look like. Old Age Security payments went up 1.2% for the July-to-September 2026 quarter — the largest of the four scheduled increases so far this year. Combined with earlier adjustments, that puts OAS 2.3% higher than it was in July 2025. OAS amounts are reviewed every January, April, July, and October to track the Consumer Price Index. When the cost of living rises, the payment rises with it. When it falls, the payment simply holds steady — OAS is protected from ever decreasing. The new maximum monthly amounts Age Group April–June 2026 July–September 2026 Monthly Increase 65 to 74 $743.05 $751.97 +$8.92 75 and older $817.36 $827.17 +$9.81 Seniors 75 and up sit higher because of the permanent 10% top-up the federal government added to that age group's OAS back in July 2022. That bump applies...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments